349 related articles for article (PubMed ID: 17473310)
1. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
2. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.
Hara H; Ishihara C; Takeuchi A; Imanishi T; Xue L; Morris SW; Inui M; Takai T; Shibuya A; Saijo S; Iwakura Y; Ohno N; Koseki H; Yoshida H; Penninger JM; Saito T
Nat Immunol; 2007 Jun; 8(6):619-29. PubMed ID: 17486093
[TBL] [Abstract][Full Text] [Related]
3. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
4. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.
Lin X; Wang D
Semin Immunol; 2004 Dec; 16(6):429-35. PubMed ID: 15541657
[TBL] [Abstract][Full Text] [Related]
5. CARD9 versus CARMA1 in innate and adaptive immunity.
Hara H; Saito T
Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB signaling in lymphocytes: a new cast of characters.
Lucas PC; McAllister-Lucas LM; Nunez G
J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
[TBL] [Abstract][Full Text] [Related]
7. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
8. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
9. CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.
Oruganti SR; Edin S; Grundström C; Grundström T
Mol Immunol; 2011 Jul; 48(12-13):1448-60. PubMed ID: 21513986
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
Thome M; Weil R
Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
[TBL] [Abstract][Full Text] [Related]
12. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
Gross O; Grupp C; Steinberg C; Zimmermann S; Strasser D; Hannesschläger N; Reindl W; Jonsson H; Huo H; Littman DR; Peschel C; Yokoyama WM; Krug A; Ruland J
Blood; 2008 Sep; 112(6):2421-8. PubMed ID: 18192506
[TBL] [Abstract][Full Text] [Related]
13. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
Edin S; Oruganti SR; Grundström C; Grundström T
Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
[TBL] [Abstract][Full Text] [Related]
15. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
16. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
Courts C; Montesinos-Rongen M; Martin-Subero JI; Brunn A; Siemer D; Zühlke-Jenisch R; Pels H; Jürgens A; Schlegel U; Schmidt-Wolf IG; Schaller C; Reifenberger G; Sabel M; Warnecke-Eberz U; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2007 Mar; 66(3):230-7. PubMed ID: 17356384
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
18. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.
Gross O; Gewies A; Finger K; Schäfer M; Sparwasser T; Peschel C; Förster I; Ruland J
Nature; 2006 Aug; 442(7103):651-6. PubMed ID: 16862125
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory signal transduction from the Fc epsilon RI to NF-kappa B.
Klemm S; Ruland J
Immunobiology; 2006; 211(10):815-20. PubMed ID: 17113919
[TBL] [Abstract][Full Text] [Related]
20. Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.
Park JH; Bae JY; Park HH
Int J Mol Med; 2013 May; 31(5):1280-7. PubMed ID: 23525237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
